DuoDerm Sealing defect (2021-08-20)
DuoDerm Sealing defect (2021-08-20)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76403r-eng.php
HEATER-COOLER UNIT HCU40 (2021-08-25)
HEATER-COOLER UNIT HCU40 (2021-08-25)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76405r-eng.php
SYNGO.VIA (2021-08-25)
SYNGO.VIA (2021-08-25)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76401r-eng.php
FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted
FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted
http://www.fda.gov/news-events/press-announcements/fda-makes-significant-progress-science-based-public-health-application-review-taking-action-over-90
FDA, FTC Warn 10 Companies Illegally Selling Dietary Supplements Claiming to Treat Diabetes
FDA, FTC Warn 10 Companies Illegally Selling Dietary Supplements Claiming to Treat Diabetes
http://www.fda.gov/news-events/press-announcements/fda-ftc-warn-10-companies-illegally-selling-dietary-supplements-claiming-treat-diabetes
FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks
FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks
http://www.fda.gov/news-events/press-announcements/fda-brief-consumers-order-more-meals-and-groceries-online-fda-plans-public-meeting-address-food
FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids
FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-announces-public-workshop-reconsider-mandatory-prescriber-education-opioids
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (Vancomycin Hydrochloride for Oral Solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit
Coronavirus (COVID-19) Update: September 7, 2021
Coronavirus (COVID-19) Update: September 7, 2021
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-september-7-2021